vs
永利度假村有限公司（RRR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是永利度假村有限公司的1.5倍（$772.1M vs $507.3M），永利度假村有限公司净利率更高（16.3% vs 12.7%，领先3.6%），Revvity同比增速更快（5.9% vs 1.9%），过去两年Revvity的营收复合增速更高（9.0% vs 2.1%）
永利度假村有限公司是总部位于美国内华达州帕拉代斯的上市企业，专注于高端酒店与赌场的开发及运营。公司由前梦幻度假村集团董事长兼首席执行官史蒂夫·永利于2002年创立，现任首席执行官为克雷格·比林斯，截至2020年共开发了6处物业。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
RRR vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$507.3M
营收增速更快
RVTY
高出4.0%
1.9%
净利率更高
RRR
高出3.6%
12.7%
两年增速更快
RVTY
近两年复合增速
2.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $507.3M | $772.1M |
| 净利润 | $82.7M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 28.3% | 14.5% |
| 净利率 | 16.3% | 12.7% |
| 营收同比 | 1.9% | 5.9% |
| 净利润同比 | -3.8% | 3.9% |
| 每股收益（稀释后） | $0.73 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RRRRVTY
| Q1 26 | $507.3M | — | ||
| Q4 25 | $511.8M | $772.1M | ||
| Q3 25 | $475.6M | $698.9M | ||
| Q2 25 | $526.3M | $720.3M | ||
| Q1 25 | $497.9M | $664.8M | ||
| Q4 24 | $495.7M | $729.4M | ||
| Q3 24 | $468.0M | $684.0M | ||
| Q2 24 | $486.4M | $691.7M |
净利润RRRRVTY
| Q1 26 | $82.7M | — | ||
| Q4 25 | $44.7M | $98.4M | ||
| Q3 25 | $42.3M | $46.7M | ||
| Q2 25 | $56.4M | $53.9M | ||
| Q1 25 | $44.7M | $42.2M | ||
| Q4 24 | $46.6M | $94.6M | ||
| Q3 24 | $29.0M | $94.4M | ||
| Q2 24 | $35.7M | $55.4M |
毛利率RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% |
营业利润率RRRRVTY
| Q1 26 | 28.3% | — | ||
| Q4 25 | 28.1% | 14.5% | ||
| Q3 25 | 27.6% | 11.7% | ||
| Q2 25 | 31.9% | 12.6% | ||
| Q1 25 | 31.0% | 10.9% | ||
| Q4 24 | 28.7% | 16.3% | ||
| Q3 24 | 27.9% | 14.3% | ||
| Q2 24 | 28.8% | 12.4% |
净利率RRRRVTY
| Q1 26 | 16.3% | — | ||
| Q4 25 | 8.7% | 12.7% | ||
| Q3 25 | 8.9% | 6.7% | ||
| Q2 25 | 10.7% | 7.5% | ||
| Q1 25 | 9.0% | 6.4% | ||
| Q4 24 | 9.4% | 13.0% | ||
| Q3 24 | 6.2% | 13.8% | ||
| Q2 24 | 7.3% | 8.0% |
每股收益（稀释后）RRRRVTY
| Q1 26 | $0.73 | — | ||
| Q4 25 | $0.74 | $0.86 | ||
| Q3 25 | $0.68 | $0.40 | ||
| Q2 25 | $0.95 | $0.46 | ||
| Q1 25 | $0.75 | $0.35 | ||
| Q4 24 | $0.78 | $0.77 | ||
| Q3 24 | $0.48 | $0.77 | ||
| Q2 24 | $0.59 | $0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $7.3B |
| 总资产 | — | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $142.5M | $919.9M | ||
| Q3 25 | $129.8M | $931.4M | ||
| Q2 25 | $145.2M | $991.8M | ||
| Q1 25 | $150.6M | $1.1B | ||
| Q4 24 | $164.4M | $1.2B | ||
| Q3 24 | $117.5M | $1.2B | ||
| Q2 24 | $136.4M | $2.0B |
总债务RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $3.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $208.3M | $7.3B | ||
| Q3 25 | $219.6M | $7.4B | ||
| Q2 25 | $203.4M | $7.6B | ||
| Q1 25 | $247.1M | $7.6B | ||
| Q4 24 | $215.1M | $7.7B | ||
| Q3 24 | $175.5M | $7.9B | ||
| Q2 24 | $159.0M | $7.9B |
总资产RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $12.2B | ||
| Q3 25 | $4.1B | $12.1B | ||
| Q2 25 | $4.0B | $12.4B | ||
| Q1 25 | $4.1B | $12.4B | ||
| Q4 24 | $4.0B | $12.4B | ||
| Q3 24 | $4.0B | $12.8B | ||
| Q2 24 | $4.0B | $13.4B |
负债/权益比RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 16.30× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 15.84× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $156.6M | $182.0M | ||
| Q3 25 | $168.3M | $138.5M | ||
| Q2 25 | $158.4M | $134.3M | ||
| Q1 25 | $126.2M | $128.2M | ||
| Q4 24 | $148.2M | $174.2M | ||
| Q3 24 | $131.0M | $147.9M | ||
| Q2 24 | $142.5M | $158.6M |
自由现金流RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | $77.7M | $161.8M | ||
| Q3 25 | $74.6M | $120.0M | ||
| Q2 25 | $80.3M | $115.5M | ||
| Q1 25 | $58.0M | $112.2M | ||
| Q4 24 | $121.4M | $149.8M | ||
| Q3 24 | $50.7M | $125.6M | ||
| Q2 24 | $64.0M | $136.6M |
自由现金流率RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 15.2% | 21.0% | ||
| Q3 25 | 15.7% | 17.2% | ||
| Q2 25 | 15.3% | 16.0% | ||
| Q1 25 | 11.6% | 16.9% | ||
| Q4 24 | 24.5% | 20.5% | ||
| Q3 24 | 10.8% | 18.4% | ||
| Q2 24 | 13.1% | 19.7% |
资本支出强度RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 15.4% | 2.6% | ||
| Q3 25 | 19.7% | 2.6% | ||
| Q2 25 | 14.9% | 2.6% | ||
| Q1 25 | 13.7% | 2.4% | ||
| Q4 24 | 5.4% | 3.4% | ||
| Q3 24 | 17.2% | 3.3% | ||
| Q2 24 | 16.2% | 3.2% |
现金转化率RRRRVTY
| Q1 26 | — | — | ||
| Q4 25 | 3.51× | 1.85× | ||
| Q3 25 | 3.98× | 2.97× | ||
| Q2 25 | 2.81× | 2.49× | ||
| Q1 25 | 2.82× | 3.03× | ||
| Q4 24 | 3.18× | 1.84× | ||
| Q3 24 | 4.53× | 1.57× | ||
| Q2 24 | 4.00× | 2.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RRR
| Casino | $340.5M | 67% |
| Food and beverage | $90.3M | 18% |
| Room | $45.5M | 9% |
| Other | $26.2M | 5% |
| Native American management and development fees | $4.7M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
